Overview
AI-powered clinical decision support engine providing evidence-based medical answers for healthcare professionals.
Funding
Amounts as reported; USD estimates shown only when they matchListed 3 funding records. Latest funding: $250M (Series D), Jan 21, 2026.
1 listed record lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 27, 2026 | — | Andreessen Horowitz, DST Global, Google Ventures, Kleiner Perkins, NVIDIA, Sequoia Capital, Thrive Capital | 1 source Source ↗ |
Evidence OpenEvidence valuation hit $15B post $250 million funding roundOn 2026/9/27, Business Insider reported that OpenEvidence, a US medical AI search company, reached a valuation of USD 15 billion after completing USD 250 million in funding. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Andreessen Horowitz, DST Global, Google Ventures, Kleiner Perkins, NVIDIA, Sequoia Capital, Thrive Capital | |||
| Jan 21, 2026 | $250M · Series D | DST Global, Google Ventures, Greycroft, Henry Kravis, ICONIQ Capital, Kleiner Perkins, Mayo Clinic, Meritech Capital Partners, Nvidia GPU Ventures, Sequoia Capital, Thrive Capital | No source link |
Evidence OpenEvidence raises USD 250 million in Series D financingOn 2026-01-21, according to Xiniu Data, OpenEvidence completed Series D financing, raising USD 250 million. Investors were Nvidia GPU Ventures, Henry Kravis, Mayo Clinic, DST and others. Translated source brief, not a quotation. Check the original before citing. Sources · 0
DST Global, Google Ventures, Greycroft, Henry Kravis, ICONIQ Capital, Kleiner Perkins, Mayo Clinic, Meritech Capital Partners, Nvidia GPU Ventures, Sequoia Capital, Thrive Capital | |||
| Oct 23, 2025 | $200M | Blackstone, Bond Capital, Coatue, Craft Ventures, Google Ventures, Kleiner Perkins, Sequoia Capital, Thrive Capital | 1 source Source ↗ |
Evidence OpenEvidence raises USD 200 million at USD 6 billion valuationOn 2025/10/23, NYT reported that medical AI search company OpenEvidence had raised USD 200 million at a USD 6 billion valuation. It did not disclose specific investors or revenue and focuses on evidence-based medical Q&A for doctors and researchers. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Blackstone, Bond Capital, Coatue, Craft Ventures, Google Ventures, Kleiner Perkins, Sequoia Capital, Thrive Capital | |||
Select ▸ on a row to see its source brief and links.
Valuation
Amounts as reported; USD estimates shown only when they matchListed 3 valuation records. Latest valuation: $6B, Oct 23, 2025.
2 listed records lack a clear date or positive USD estimate for the chart.
| Date | Amount | Investors | Sources |
|---|---|---|---|
| Sep 27, 2026 | — | Andreessen Horowitz, DST Global, Google Ventures, Kleiner Perkins, NVIDIA, Sequoia Capital, Thrive Capital | 1 source Source ↗ |
Evidence OpenEvidence valuation hit $15B post $250 million funding roundOn 2026/9/27, Business Insider reported that OpenEvidence, a US medical AI search company, reached a valuation of USD 15 billion after completing USD 250 million in funding. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Andreessen Horowitz, DST Global, Google Ventures, Kleiner Perkins, NVIDIA, Sequoia Capital, Thrive Capital | |||
| Jan 21, 2026 | — · Series D | DST Global, Google Ventures, Greycroft, Henry Kravis, ICONIQ Capital, Kleiner Perkins, Mayo Clinic, Meritech Capital Partners, Nvidia GPU Ventures, Sequoia Capital, Thrive Capital | No source link |
Evidence OpenEvidence raises USD 250 million in Series D financingOn 2026-01-21, according to Xiniu Data, OpenEvidence completed Series D financing, raising USD 250 million. Investors were Nvidia GPU Ventures, Henry Kravis, Mayo Clinic, DST and others. Translated source brief, not a quotation. Check the original before citing. Sources · 0
DST Global, Google Ventures, Greycroft, Henry Kravis, ICONIQ Capital, Kleiner Perkins, Mayo Clinic, Meritech Capital Partners, Nvidia GPU Ventures, Sequoia Capital, Thrive Capital | |||
| Oct 23, 2025 | $6B | Blackstone, Bond Capital, Coatue, Craft Ventures, Google Ventures, Kleiner Perkins, Sequoia Capital, Thrive Capital | 1 source Source ↗ |
Evidence OpenEvidence raises USD 200 million at USD 6 billion valuationOn 2025/10/23, NYT reported that medical AI search company OpenEvidence had raised USD 200 million at a USD 6 billion valuation. It did not disclose specific investors or revenue and focuses on evidence-based medical Q&A for doctors and researchers. Translated source brief, not a quotation. Check the original before citing. Sources · 1
Blackstone, Bond Capital, Coatue, Craft Ventures, Google Ventures, Kleiner Perkins, Sequoia Capital, Thrive Capital | |||
Select ▸ on a row to see its source brief and links.
Revenue
Amounts as reported; USD estimates shown only when they matchListed 3 revenue records. Latest revenue: $300M (ARR), Jul 21, 2026.
| Revenue date | Amount | Sources |
|---|---|---|
| Jul 21, 2026 | $300M (ARR) | 1 source Source ↗ |
Evidence OpenEvidence reaches USD 300 million ARR, 860 thousand clinician usersOn 2026/7/21, LinkedIn reported that US medical AI question-answering platform OpenEvidence had reached USD 300 million ARR, with approximately 860 thousand clinician users. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
| Dec 18, 2025 | $150M (ARR) | 1 source Source ↗ |
Evidence OpenEvidence reaches USD 150 million ARROn 2025/12/18, X reported that medical AI search company OpenEvidence had reached USD 150 million in annual recurring revenue. It did not disclose its latest funding or valuation. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
| Jul 17, 2025 | $50M (ARR) | 1 source Source ↗ |
Evidence OpenEvidence reaches USD 50 million ARROn 2025/7/17, LinkedIn reported that AI scientific search platform OpenEvidence had disclosed USD 50 million in annual recurring revenue. Translated source brief, not a quotation. Check the original before citing. Sources · 1
| ||
Select ▸ on a row to see its source brief and links.
Team, products & investors
Explore
More Industry apps companies
Sources · 0Sources & provenance
English text is maintained separately from the original record. Consult the original source before citing a fact.
No source links are available for this profile.
Original source text
Names may use phonetic renderings when no English name is supplied. The original wording is retained below.
面向医生的循证医学AI问答引擎 AI-powered clinical decision support engine providing evidence-based medical answers for healthcare professionals.